10x Genomics Inc (TXG) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
10x Genomics Inc   (NASDAQ: TXG)


10x Genomics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is 10x Genomics Inc's ROI in the second quarter of 2026?
10x Genomics Inc recorded a cumulative net loss of $-75 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -8.39%.

Within the Healthcare sector 57 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2625 to 2665.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 15.31 % 19.42 % 18.71 % 11.05 % 4.88 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 912 902 888 880 868
Return On Investment (TTM) -8.39 % -2.56 % -5.08 % -9.37 % -10.89 %
TXG's Overall Ranking # 2665 # 2625 # 2251 # 2391 # 2403
Seq. Investment Change TTM 1.24 % 3.11 % 5.3 % 4.9 % 4.85 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -75 -23 -44 -76 -85

TXG Company Profile >> Back to TXG Roi Comparisons >> See Annual TXG Return On Investment



Return On Investment TXG's Ranking
Within: No.
Industry # 4
Sector # 58
Overall # 2665

Return On Investment Statistics
High Average Low
-2.36 %
-24.12 %
-76.18 %
(Sep 30 2025)   (Dec 31 2020)







Financial Statements
10x Genomics Inc's II. Quarter Investments $ 912 Millions TXG's Balance sheet
10x Genomics Inc's II. Quarter Income $ -18 Millions Quarterly TXG's Income Statement
TXG's Income by Division See TXG's Income by Division


TXG Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 804 715 759 825 836
Y / Y Investment Growth 12.43 % -5.77 % -8.01 % -1.25 % 12.45 %
Net Income in Millions -44 -183 -255 -166 -58
Y / Y Net Income Growth - - - - -
Annual Return On Investment -5.42 % -25.54 % -33.61 % -20.12 % -6.97 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TXG's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TXG's Competitors
Subscribers only: Roi for 10x Genomics Inc's Suppliers
Subscribers only: Return On Investment for TXG's Customers

Other Ratios
TXG's Roa TXG's Inventory Turnover Ratio TXG's Growth Rates TXG's Dividend Statistics
TXG's Profitability Ratios TXG's Asset Turnover Ratio TXG's Dividend Growth
TXG's Roe TXG's Valuation Ratios TXG's Financial Strength Ratios TXG's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:37:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.